From: Improved survival for non-Hodgkin lymphoma patients in New South Wales, Australia
 | 5-yr RSR (%) | RER* | 95% CI†| P-value |
---|---|---|---|---|
Period of survival | Â | Â | Â | <0.0001 |
   1990-1994 | 53.3 | 1.00 |  |  |
   1995-1999 | 55.9 | 0.89 | (0.84-0.94) |  |
   2000-2004 | 62.1 | 0.74 | (0.69-0.78) |  |
Sex | Â | Â | Â | <0.0001 |
   Males | 57.5 | 1.00 |  |  |
   Females | 57.5 | 0.86 | (0.82-0.91) |  |
Age at diagnosis (years) | Â | Â | Â | <0.0001 |
   15-44 | 66.6 | 1.00 |  |  |
   45-59 | 70.3 | 1.03 | (0.94-1.13) |  |
   60-74 | 58.3 | 1.56 | (1.44-1.70) |  |
   75-89 | 39.5 | 2.95 | (2.71-3.20) |  |
NHL grouping | Â | Â | Â | <0.0001 |
   Agressive B-cell | 45.2 | 1.00 |  |  |
   Indolent B-cell | 73.1 | 0.30 | (0.28-0.32) |  |
   Other NHL | 61.0 | 0.92 | (0.86-0.97) |  |
   NHL NOS | 46.6 | 0.62 | (0.54-0.71) |  |